Address

1515 N University Dr. Suite 220 Coral Springs, Fl 33071

Phone

+1 888-853-0256

Address

1515 N University Dr. Suite 220 Coral Springs, Fl 33071

Phone

+1 888-853-0256

What is the Paraquat Lawsuit About

If you or someone you know has been diagnosed with Parkinson’s disease after exposure to Paraquat?

The Paraquat lawsuit centers around claims that exposure to a toxic herbicide, Paraquat, has led to serious health issues, particularly Parkinson’s disease.

Key point about Paraquat lawsuit

Get Free Case Review

We build trust, understand needs and provide solutions

Legal Action

Your Legal Rights

If you or someone you know has been diagnosed with Parkinson’s disease after exposure to Paraquat, you may have grounds for a legal claim. Contacting a specialized legal team can help you understand your rights and potentially secure compensation for your losses.

A landmark trial for the Paraquat lawsuit is scheduled for April 2025 in Philadelphia. However, it’s anticipated that many of these cases may reach settlements before going to trial. The defendants, Chevron and Syngenta, likely prefer private settlements to avoid a jury trial, which could create a precedent for future settlements and reveal more details to the public.

A landmark trial for the Paraquat lawsuit is scheduled for April 2025 in Philadelphia. However, it’s anticipated that many of these cases may reach settlements before going to trial. The defendants, Chevron and Syngenta, likely prefer private settlements to avoid a jury trial, which could create a precedent for future settlements and reveal more details to the public.

The number of Paraquat lawsuits in Philadelphia has surged nearly 50% in the first half of 2024. Judge Joshua Roberts noted that case numbers rose from approximately 500 at the start of the year to 728 by mid-June. This increase is largely due to two factors:

  1. Positive Outcomes in State Court: Previous cases, such as those involving Elmiron eye injuries, have shown better outcomes in Pennsylvania state courts compared to federal courts.
  2. Concerns Over Expert Dismissals in MDL: Lawyers are wary of early dismissals of key experts and cases in the federal MDL, as happened in the Zantac lawsuits. This has driven them to file cases in state court to avoid similar pitfalls.

The decision to move cases to state court in Philadelphia highlights attorneys’ strategic preferences following unfavorable rulings in federal MDLs. This trend could continue as lawyers seek jurisdictions with better track records for plaintiff verdicts.

By monitoring these developments, it’s clear the legal landscape for Paraquat cases is shifting, with significant implications for future litigation and settlements.